Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,898 | -3,272 | -1,904 | -4,255 | -2,890 |
| Depreciation Amortization | 4 | 3 | 2 | 10 | 8 |
| Accounts receivable | 44 | -74 | 5 | -23 | -14 |
| Other Working Capital | 364 | 455 | 646 | 961 | 698 |
| Other Operating Activity | 115 | 142 | 26 | 119 | 65 |
| Operating Cash Flow | $-4,370 | $-2,747 | $-1,225 | $-3,188 | $-2,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | -3 | -2 |
| Other Investing Activity | 28 | 19 | 9 | 36 | 27 |
| Investing Cash Flow | $27 | $17 | $8 | $33 | $25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,990 | 6,990 | N/A | 4,102 | 1,960 |
| Other Financing Activity | 130 | 130 | 115 | 0 | 0 |
| Financing Cash Flow | $7,120 | $7,120 | $115 | $4,102 | $1,960 |
| Beginning Cash Position | 2,217 | 2,217 | 2,217 | 1,271 | 1,271 |
| End Cash Position | 4,994 | 6,608 | 1,115 | 2,217 | 1,122 |
| Net Cash Flow | $2,777 | $4,390 | $-1,102 | $946 | $-149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,370 | -2,747 | -1,225 | -3,188 | -2,134 |
| Capital Expenditure | -1 | -1 | -1 | -3 | -2 |
| Free Cash Flow | -4,371 | -2,748 | -1,227 | -3,191 | -2,135 |